iShares US Healthcare E.T.F. (IYH) Buy, Sell…

Home

Daily Stock Opinions and Ratings

iShares US Healthcare E.T.F. (IYH)

64.24

+0.26 (0.41%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

21 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

The iShares US Healthcare E.T.F. (IYH-N) is showing promising trends as experts point to improving expectations in the Medical Loss Ratio (MLR) for managed-care companies. This could signal a positive turnaround for many firms operating within the healthcare sector. Additionally, the potential for greater clarity surrounding Medicare Advantage plans may further enhance the attractiveness of healthcare investments. As healthcare solutions become pivotal in an evolving market, these factors present a constructive outlook combined with the resilience of these companies amidst potential regulatory changes. The overall sentiment is one of cautious optimism, anticipating that these developments could bolster financial performance and investor confidence in the sector.

Consensus

Positive

Valuation

Fair Value

Similar

Vanguard, VHT

COMMENT

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

BUY

Owns all the large US healthcare names. Continues to move along at a very nice clip.

BUY

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

BUY ON WEAKNESS

Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.

BUY

Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.

Showing 16 to 20 of 20 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

iShares US Healthcare E.T.F. (IYH)